Ligand Pharmaceuticals Incorporated
LGND
$213.21
-$5.77-2.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.26% | 10.38% | 171.21% | 17.29% | -18.45% |
| Total Receivables | -20.15% | 18.90% | 34.59% | -1.02% | 0.87% |
| Inventory | 45.36% | -23.31% | -23.17% | 5.99% | 3.54% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.17% | -17.19% | -82.55% | 21.83% | 273.27% |
| Total Current Assets | 3.98% | 10.39% | 113.61% | 14.10% | -6.71% |
|
|
|||||
| Total Current Assets | 3.98% | 10.39% | 113.61% | 14.10% | -6.71% |
| Net Property, Plant & Equipment | 42.30% | -34.78% | -4.71% | 10.78% | 8.47% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | -3.52% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | -3.52% |
| Total Other Intangibles | -3.59% | -3.47% | -6.64% | -3.20% | -3.10% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.52% | -0.78% | 2.95% | 3.10% | -1.35% |
| Total Assets | -1.83% | 5.68% | 55.68% | 4.77% | -3.86% |
|
|
|||||
| Total Accounts Payable | 62.57% | -11.99% | -57.14% | 59.97% | 2.54% |
| Total Accrued Expenses | 1.35% | 40.42% | 37.25% | -28.70% | -17.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.77% | 2.75% | -2.16% | 26.05% | -31.55% |
| Total Finance Division Other Current Liabilities | 20.75% | -20.73% | -87.32% | 27.74% | 518.06% |
| Total Other Current Liabilities | 20.75% | -20.73% | -87.32% | 27.74% | 518.06% |
| Total Current Liabilities | 8.60% | 22.62% | -52.82% | 10.31% | 58.12% |
|
|
|||||
| Total Current Liabilities | 8.60% | 22.62% | -52.82% | 10.31% | 58.12% |
| Long-Term Debt | 0.16% | 0.16% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.60% | -4.19% | -4.62% | 29.85% | -39.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -22.19% | 20.37% | -8.99% | 6.42% | -30.29% |
| Total Liabilities | -1.59% | 3.19% | 338.56% | 9.26% | -1.29% |
|
|
|||||
| Common Stock & APIC | -0.87% | 10.49% | 1.11% | 5.31% | 0.94% |
| Retained Earnings | -2.19% | 5.17% | 25.32% | 1.06% | -8.51% |
| Treasury Stock & Other | -36.25% | -9.30% | 9.75% | 643.44% | 73.70% |
| Total Common Equity | -1.96% | 7.06% | 14.68% | 4.15% | -4.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.96% | 7.06% | 14.68% | 4.15% | -4.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.96% | 7.06% | 14.68% | 4.15% | -4.20% |
|
|
|||||